Socioeconomic Disparities in Breast Cancer Survival: Examining Potential Mediator Role of Oncotype DX(ODX) Test and Stage at Diagnosis Among HR+/HER2- Breast Cancer Women
Low SES is associated with higher hazard rates of overall and cause-specific death among women with breast cancer, even after adjustment. Differences in Oncotype DX (ODX) testing and stage at diagnosis explained part of these disparities. Targeted interventions are needed to improve access to genomic testing and early detection to reduce SES-related disparities in breast cancer outcomes.
Authors
- Tekeda Ferguson (ORCID: https://orcid.org/0000-0003-2880-4935)
- Edward Peters (ORCID: https://orcid.org/0000-0003-4928-6532)
- Pratibha Shrestha (ORCID: https://orcid.org/0000-0003-1254-290X)
- Mei‐Chin Hsieh (ORCID: https://orcid.org/0000-0001-7842-1225)
- Qingzhao Yu (ORCID: https://orcid.org/0000-0001-8194-0798)
- Quincy Chu (ORCID: https://orcid.org/0009-0002-4837-5218)
- Edward Trapido (ORCID: https://orcid.org/0000-0002-9612-4555)
- Xiao‐Cheng Wu (ORCID: https://orcid.org/0000-0003-3663-5027)
Institutions
- University of Florida (US)
- Howard University Hospital (US)
- University of Nebraska Medical Center (US)
- Louisiana State University Health Sciences Center New Orleans (US)
Publication Details
- Journal
- Cancers
- Published
- 2025-05-28
- DOI
- https://doi.org/10.3390/cancers17111802
- Citations
- 1
- Primary Topic
- Breast Cancer Treatment Studies
- Type
- article
- Field-Weighted Citation Impact
- 0.94